Effects of Whey and Collagen on FFM, Muscle Strength and Wound Healing in Elderly Surgical Patients
NCT ID: NCT04496856
Last Updated: 2021-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2020-05-10
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Preoperative Whey Protein and Exercise Support on Recovery After Total Hip Arthroplasty
NCT07329010
Effects of Whey Protein and Collagen Supplementation
NCT04213586
Geriatric Recovery Using Inpatient and Post-hospitalization Supplementation
NCT03904615
Whey Protein and Carbohydrates in ERAS for Recovery After Thyroidectomy: A Cohort Study
NCT06607965
Combined Whey Protein and Collagen Supplementation in Resistance-Trained Men
NCT07171411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Collagen
Participants of this arm are going to consume 30 g of collagen peptides daily for 30 days
Whey protein and Collagen supplementation
Participants of each arm will consume 30 g daily of the assigned protein supplementation for 30 days. The protein supplementation will be given as protein powder which the participants will have to dissolve in cold drinks. During the intervention fat free mass, muscle strength, functional ability, wound healing and life quality of the participants will be monitored.
Whey Protein
Participants of this arm are going to consume 30 g of whey protein daily for 30 days
Whey protein and Collagen supplementation
Participants of each arm will consume 30 g daily of the assigned protein supplementation for 30 days. The protein supplementation will be given as protein powder which the participants will have to dissolve in cold drinks. During the intervention fat free mass, muscle strength, functional ability, wound healing and life quality of the participants will be monitored.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whey protein and Collagen supplementation
Participants of each arm will consume 30 g daily of the assigned protein supplementation for 30 days. The protein supplementation will be given as protein powder which the participants will have to dissolve in cold drinks. During the intervention fat free mass, muscle strength, functional ability, wound healing and life quality of the participants will be monitored.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled elective knee- or hip surgery
* Must be able to understand and speak danish
* Must be able to chew and swallow food with a regular consistency
* Must be able to consume the assigned protein supplementation
* Must be able to consent participation
Exclusion Criteria
* Demensia
* Critical complications to the surgery which prevents the patient from participating in the rehabilitation program
* Plasma-creatinin above 250 micromol/L
* Palliative patients
* Known intolerance of whey protein and/or collagen
* Patients with a pacemaker
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev and Gentofte Hospital
OTHER
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Rikardt Andersen
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herlev/Gentofte Hospital
Gentofte Municipality, Hellerup, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ValleKollagen
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.